Yüklüyor......
A novel tumor spheroid model identifies selective enhancement of radiation by an inhibitor of oxidative phosphorylation
There is a need for preclinical models that can enable identification of novel radiosensitizing drugs in clinically relevant high-throughput experiments. We used a new high-throughput compatible total cell kill spheroid assay to study the interaction between drugs and radiation in order to identify...
Kaydedildi:
| Yayımlandı: | Oncotarget |
|---|---|
| Asıl Yazarlar: | , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Impact Journals LLC
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6731106/ https://ncbi.nlm.nih.gov/pubmed/31523395 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.27166 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|